Anduril Options Security Clearance: What to Report

By Joe Forish, CFA, CFP®|Published On: Sep 19, 2026|Categories: Financial Planning|

You ran the numbers. Or someone ran them for you, which honestly might have been the better call. Either way, you now know that exercising your Anduril options will create a tax bill in the low six figures – payable in cash, next April, on shares you cannot sell yet. If you have not run those numbers yet, start with the Anduril employee equity guide, which works through the AMT math in full. For cleared employees, the Anduril options security clearance question comes right behind that one. Congratulations, by the way. That is the good version of this problem.

Every article you have found so far treats the funding decision as a purely technical question: interest rates, loan structures, lender comparisons. Fine advice, except it skips the question underneath your question. You hold a security clearance, and what you actually want to know is whether any of this puts it at risk – and what, if anything, you are obligated to tell someone.

Most people brace for a scary answer when the Anduril options security clearance question comes up. The actual answer is more reassuring than most people expect. There is, however, one nuance that changes everything about which funding path you choose.

The Real Question Behind the Clearance Concern

Cleared employees face no prohibition on holding company equity. Becoming wealthier through a documented compensation event is not a problem. An option exercise at your own employer is arguably the most explicable wealth event that exists – you have a grant agreement, an exercise confirmation, a board-approved 409A valuation, and an IRS form documenting the entire transaction.

The Anduril options security clearance risk is not the exercise. It is the liability you might create to pay for it. That distinction – asset versus obligation – separates a routine financial event from a genuine Guideline F concern. Understanding it before you commit to a funding structure is the whole point of this article.

What Anduril Option Exercises Actually Trigger Under SEAD 3

Reporting obligations for cleared personnel come from Security Executive Agent Directive 3 (SEAD 3). Implementation varies by agency, program, and contractor. Your facility security officer (FSO) is the authority on what your specific program requires – not this article, not a clearance forum, and certainly not the colleague down the hall.

One category is worth understanding before you exercise, because it is the one people most commonly assume applies to them.

Significant Unexplained Affluence: What the Term Actually Means

“Significant unexplained affluence” appears in SEAD 3 as a reportable change in financial circumstances. People see the word affluence and immediately start sweating through their collared shirts. Understandable. However, the operative word is unexplained – not affluence.

The counterintelligence concern targets money that arrives from a source you cannot or will not account for. An Anduril option grant that shows up in your Carta account, triggers an AMT calculation on your tax return, and generates a broker confirmation is the opposite of unexplained. It is, in fact, one of the most thoroughly documented wealth events that exists.

Compare that profile with the actual concern the language describes: a lifestyle that visibly outruns a known salary, with no paper trail behind it. Those are not the same situation. Adjudicators treat them very differently.

Before you assume your option exercise triggers a reporting obligation on this basis, ask yourself one question: can I explain exactly where this money came from? For an Anduril option exercise, the answer is always yes. Keep the documents where you can find them, and move on.

The remaining financial categories in SEAD 3 concern obligations that go unpaid long enough to become a matter of record: delinquencies, liens, garnishments, foreclosures. Notably, none of those result from acquiring an option. All of them can result from how you fund one – which is the subject of the rest of this article.

What Guideline F Actually Penalizes

Guideline F governs financial issues in the federal adjudicative guidelines, and those issues remain among the most common grounds for clearance denial and revocation. Everyone cites that statistic. Fewer people cite the part that actually matters: what, specifically, triggers it.

The disqualifying conditions cluster around a consistent theme. They cover:

Inability to satisfy debts – delinquencies, defaults, collections, charge-offs, repossessions, foreclosures
Unwillingness to satisfy debts, treated more harshly than inability
A history of not meeting financial obligations
Failure to file or pay taxes
Fraudulent or deceptive financial conduct
Unexplained affluence and compulsive behaviors such as problem gambling

Read that list with your exercise decision in mind. Acquiring an asset triggers nothing on it. A liability that went bad triggers almost everything.

The Logic Behind Guideline F

The underlying rationale is not moral judgment. It is about susceptibility. A person under financial pressure is a person who can potentially be induced – and the adjudicative process identifies that vulnerability before an adversary does. The Center for Development of Security Excellence provides detailed training resources on exactly how this works in practice.

This reframes the entire funding decision. The question is not “can I afford this exercise if things go well?” The real question is: what happens to this obligation if things go badly, and does that scenario put me under financial pressure that someone else could exploit?

How to Fund an Anduril Option Exercise Without Clearance Risk

The tax-optimal structure and the clearance-safe structure are not always the same one. Below, the five most common funding routes rank by Anduril options security clearance exposure – lowest risk to highest. None is universally correct. Each depends on your specific balance sheet.

1. Cash on Hand – Lowest Exposure

You exercise what you can pay for outright. No new liability, therefore nothing for Guideline F to attach to. The constraint is that it limits the exercise size.

That constraint, however, is exactly why partial exercises spread across multiple tax years so often win. You reduce the AMT hit per year and keep the funding inside what your cash flow supports. A smaller exercise you can comfortably afford is almost always preferable to a larger one that creates a liability you are hoping to outlast.

2. Selling Into a Tender Offer – Low Exposure

When Anduril opens a tender window, proceeds from shares you sell can fund the exercise of shares you keep. No borrowing required. This approach avoids creating any new obligation at all.

The limitation is timing – you do not control when a window opens, and tender offers typically cap participation at a percentage of your vested holdings. Treat any tender window you can access as a scarce resource with more than one possible use, and allocate it deliberately rather than reflexively.

3. Non-Recourse Advance From a Pre-IPO Specialist – Low Exposure, With Caveats

These firms advance the exercise cost and associated taxes in exchange for a share of eventual upside. If the shares end up worthless, you owe nothing – which structurally is the safest possible shape from a Guideline F perspective, because there is no obligation that can go delinquent.

Two caveats apply, however. First, these arrangements are expensive, often materially so when you total what you give up. Second, they generally require company consent, because they involve an interest in restricted shares. At a defense contractor with tight transfer restrictions, that consent may not be available. Confirm with Anduril’s stock administration before you spend time on this route.

4. Securities-Based or Margin Lending – Higher Exposure

Borrowing against a brokerage portfolio to fund the exercise creates a callable liability. In a market drawdown, the lender can demand repayment at precisely the moment your net worth has declined and your illiquid Anduril shares cannot be sold to cover it.

That sequence – forced repayment you cannot make, on debt secured by an asset that just fell – is the textbook shape of a Guideline F problem. Margin debt is not automatically disqualifying. Margin debt sized so that a bad market forces a default is a genuine risk.

5. Recourse Personal Debt – Depends Entirely on Serviceability

A HELOC, personal loan, or line of credit works fine if you can service it from your salary alone – indefinitely, with no contribution from the Anduril shares. Nevertheless, it carries real risk if the repayment plan assumes a liquidity event that has no fixed date.

Anduril has not announced an IPO timeline. Any funding structure whose repayment depends on one arriving by a particular year is a structure built on a number nobody actually has.

The Stress Test Worth Running Before You Commit

Before committing to any structure, run one scenario. Just one.

The 409A falls 40% and stays there. The IPO slips three years. You are servicing this obligation on your salary alone for that entire period.

If that scenario produces debt you can carry without missing a payment, the structure is defensible. If it produces delinquency, the structure is wrong – no matter how well it optimizes on taxes, and no matter how unlikely you think that outcome is.

Delinquency is not abstract in this context. Debt left unpaid past roughly the 120-day mark commonly crosses the threshold where a private cash-flow problem becomes something you are obliged to report. That is the real line your funding decision has to clear. Know where it sits before you choose a structure, not after.

You are not modelling what you expect. You are modelling what you can survive.

Why Documentation Is Itself Protective

This rarely gets mentioned in Anduril options and security clearance discussions.

Guideline F is not only a list of disqualifying conditions. It also contains mitigating conditions – circumstances under which a financial problem is considered resolved or excused. Those include:

Conditions largely beyond the person’s control, where they nonetheless acted responsibly
A good-faith effort to repay, evidenced by a plan actually being followed
Receipt of financial counseling, with clear indications the problem is under control
A reasonable, documented basis for disputing a debt

Notice what every one of those has in common. Each is a documentation standard. The adjudicative process is not asking whether your finances were ever strained. It is asking whether you behaved like someone in control of the situation – and whether you can demonstrate it.

What Good Documentation Looks Like for an Anduril Option Exercise

The analysis you do before the exercise – the modelled scenarios, the stress test, the written funding rationale, the advice you documented receiving – is not just financial planning. If anything ever goes sideways, it becomes the contemporaneous record that a responsible person made a considered decision under professional guidance.

A file assembled after the fact, once there is a problem to explain, never reads the same way. Adjudicators know the difference.

Keep the paperwork. Date everything.

What to Do, in Order

The combination of Anduril option exercise decisions and clearance reporting feels overwhelming. Fortunately, the sequence is straightforward.

First, confirm your reporting obligations with your FSO. Ask in general terms, before you have a pending transaction. You are asking what your program requires – not confessing a plan. It is a routine administrative question.

Second, model the exercise at several sizes: full, half, and a multi-year tranche schedule. The tax difference between those scenarios is usually large enough to matter significantly.

Third, price each funding route against the 40% / three-year stress test. Discard anything that fails it, regardless of what it saves in taxes. Tax efficiency means nothing if the structure creates a Guideline F vulnerability.

Fourth, check whether your chosen structure requires company consent. Third-party financing against restricted shares typically does. At Anduril, that is a real question to resolve with stock administration before you commit – not a formality.

Fifth, write down the rationale and keep it. What you decided, what you assumed, what advice you received, and when you made each decision. Dated documentation matters enormously.

Sixth, report what is reportable, promptly. A disclosed event handled on time is administrative. The same event left unreported becomes a personal conduct question under Guideline E – and that is a worse problem than the original financial one.

Frequently Asked Questions

Do I Have to Report Exercising My Anduril Stock Options?

Exercising, by itself, is generally not an enumerated reportable event under SEAD 3. However, a significant change in your financial position may be reportable depending on your agency and program. The safe path is to ask your FSO what your specific program requires, rather than deciding on your own. From an Anduril options security clearance standpoint, the documentation behind the exercise makes it straightforward to explain if anyone ever asks.

Will Taking a Loan to Fund an Anduril Option Exercise Hurt My Clearance?

Not in itself. Debt is not disqualifying – unmanageable debt is. What matters is whether the obligation stays serviceable under adverse conditions. A modest, structured loan you can pay from salary alone is a very different situation from a callable position sized against a valuation nobody has stress-tested yet. Run the stress test before you sign anything.

Is a Large Equity Windfall Treated as Unexplained Affluence Under Security Clearance Rules?

Unexplained affluence describes wealth with no accountable source. Your own cleared employer paid you this compensation, and your grant documents and tax reporting prove it. Keep the records where you can find them. The “unexplained” part is doing all the work in that phrase – and an Anduril option exercise is about as explained as it gets.

Should I Just Wait Until After an IPO to Exercise My Anduril Options?

Sometimes, but not as a default. Waiting has real costs: a larger AMT or ordinary income event at exercise, a capital gains holding period that never started, and the loss of any ability to spread the tax liability across years. Moreover, waiting concentrates the decision into the least flexible moment – when shares are publicly traded, prices are visible, and your options for managing the tax hit have narrowed considerably. Model both paths before you decide.

Who Should I Actually Talk to About Anduril Options and Security Clearance Questions?

Three different people, for three distinct questions. Your FSO handles reporting requirements. A clearance attorney is appropriate if you have an existing financial issue, a past delinquency, or anything already under review. A financial planner handles the structure, modelling, and tax analysis. Fortrove Partners can help with the third question – and only the third one. Each question requires a different specialist, and conflating them tends to produce worse answers across the board.